awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28646882-06B6EF25-185A-441A-9F2F-7AB02938EB61
Q28646882-06B6EF25-185A-441A-9F2F-7AB02938EB61
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28646882-06B6EF25-185A-441A-9F2F-7AB02938EB61
The advantages of PD1 activating chimeric receptor (PD1-ACR) engineered lymphocytes for PDL1(+) cancer therapy
P2860
Q28646882-06B6EF25-185A-441A-9F2F-7AB02938EB61
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28646882-06B6EF25-185A-441A-9F2F-7AB02938EB61
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0154a954f16f5721957ea11c77774c2c9672fb7e
P2860
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired